Company will cut price of drug after accused gouging

Associated Press reports that the company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 percent says it will roll back some of the increase. Turing Pharmaceuticals CEO Martin Shkreli that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be.